Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features

Elizabeth Yuan, Peter T. Tsai, Emily Greene-colozzi, Mustafa Sahin, David J. Kwiatkowski, Izabela A. Malinowska

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2c-del3/c-del3SynICre+) and heterozygote null/conditional hypomorphic alleles (Tsc2k/c-del3SynICre+) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.

Original languageEnglish (US)
Article numberdds262
Pages (from-to)4286-4300
Number of pages15
JournalHuman Molecular Genetics
Volume21
Issue number19
DOIs
StatePublished - Oct 2012

Fingerprint

Tuberous Sclerosis
Alleles
Survival
Brain
Neurons
Synapsins
Mutant Proteins
Interpersonal Relations
Heterozygote
Nervous System
tuberous sclerosis complex 2 protein
Proteins
Extremities
Anxiety
Phenotype
Mutation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. / Yuan, Elizabeth; Tsai, Peter T.; Greene-colozzi, Emily; Sahin, Mustafa; Kwiatkowski, David J.; Malinowska, Izabela A.

In: Human Molecular Genetics, Vol. 21, No. 19, dds262, 10.2012, p. 4286-4300.

Research output: Contribution to journalArticle

Yuan, Elizabeth ; Tsai, Peter T. ; Greene-colozzi, Emily ; Sahin, Mustafa ; Kwiatkowski, David J. ; Malinowska, Izabela A. / Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. In: Human Molecular Genetics. 2012 ; Vol. 21, No. 19. pp. 4286-4300.
@article{6a8960000c4b4701927c347a75ce25a5,
title = "Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features",
abstract = "Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2c-del3/c-del3SynICre+) and heterozygote null/conditional hypomorphic alleles (Tsc2k/c-del3SynICre+) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.",
author = "Elizabeth Yuan and Tsai, {Peter T.} and Emily Greene-colozzi and Mustafa Sahin and Kwiatkowski, {David J.} and Malinowska, {Izabela A.}",
year = "2012",
month = "10",
doi = "10.1093/hmg/dds262",
language = "English (US)",
volume = "21",
pages = "4286--4300",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features

AU - Yuan, Elizabeth

AU - Tsai, Peter T.

AU - Greene-colozzi, Emily

AU - Sahin, Mustafa

AU - Kwiatkowski, David J.

AU - Malinowska, Izabela A.

PY - 2012/10

Y1 - 2012/10

N2 - Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2c-del3/c-del3SynICre+) and heterozygote null/conditional hypomorphic alleles (Tsc2k/c-del3SynICre+) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.

AB - Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2c-del3/c-del3SynICre+) and heterozygote null/conditional hypomorphic alleles (Tsc2k/c-del3SynICre+) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.

UR - http://www.scopus.com/inward/record.url?scp=84866354915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866354915&partnerID=8YFLogxK

U2 - 10.1093/hmg/dds262

DO - 10.1093/hmg/dds262

M3 - Article

VL - 21

SP - 4286

EP - 4300

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 19

M1 - dds262

ER -